Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cameron

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Dermatology Online Journal|October 31, 2025
The role of interleukin-13 in the management of atopic dermatitis: an expert consensus panelLauren DeBusk, Natasha Atanaskova-Mesinkovska, Brooke Bartley, et al.
Nature Neuroscience|April 4, 2017
GLP-1 acts on habenular avoidance circuits to control nicotine intakeLuis M Tuesta, Zuxin Chen, Alexander Duncan, et al.
Science Translational Medicine|June 7, 2013
Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSDRaül Andero, Shaun P Brothers, Tanja Jovanovic, et al.
Bioorganic & Medicinal Chemistry|September 3, 2013
Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarkerDavid J Richard, Ryan Lena, Thomas Bannister, et al.
Journal of Medicinal Chemistry|December 16, 2024
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg VirusesMalaika D Argade, Jazmin Galván Achi, Ryan Bott, et al.
Nature Chemical Biology|June 10, 2020
Discovery of small-molecule enzyme activators by activity-based protein profilingBernard P Kok, Srijana Ghimire, Woojoo Kim, et al.
Blood|March 20, 2010
Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutantsEllen Weisberg, Hwan Geun Choi, Arghya Ray, et al.
Blood|June 16, 2021
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistanceGuang Yang, Jinhua Wang, Li Tan, et al.
Gastroenterology|March 6, 2026
A Gut-Restricted Liver X Receptor Agonist Ameliorates Liver Injury in Experimental Short Bowel SyndromeAyoung Kim, Daniel M Alligood, Lingaiah Maram, et al.
Science Advances|July 25, 2020
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibitionAnne Fassl, Christopher Brain, Monther Abu-Remaileh, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Dermatology Online Journal|October 31, 2025
The role of interleukin-13 in the management of atopic dermatitis: an expert consensus panelLauren DeBusk, Natasha Atanaskova-Mesinkovska, Brooke Bartley, et al.
Nature Neuroscience|April 4, 2017
GLP-1 acts on habenular avoidance circuits to control nicotine intakeLuis M Tuesta, Zuxin Chen, Alexander Duncan, et al.
Science Translational Medicine|June 7, 2013
Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSDRaül Andero, Shaun P Brothers, Tanja Jovanovic, et al.
Bioorganic & Medicinal Chemistry|September 3, 2013
Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarkerDavid J Richard, Ryan Lena, Thomas Bannister, et al.
Journal of Medicinal Chemistry|December 16, 2024
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg VirusesMalaika D Argade, Jazmin Galván Achi, Ryan Bott, et al.
Nature Chemical Biology|June 10, 2020
Discovery of small-molecule enzyme activators by activity-based protein profilingBernard P Kok, Srijana Ghimire, Woojoo Kim, et al.
Blood|March 20, 2010
Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutantsEllen Weisberg, Hwan Geun Choi, Arghya Ray, et al.
Blood|June 16, 2021
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistanceGuang Yang, Jinhua Wang, Li Tan, et al.
Gastroenterology|March 6, 2026
A Gut-Restricted Liver X Receptor Agonist Ameliorates Liver Injury in Experimental Short Bowel SyndromeAyoung Kim, Daniel M Alligood, Lingaiah Maram, et al.
Science Advances|July 25, 2020
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibitionAnne Fassl, Christopher Brain, Monther Abu-Remaileh, et al.
Pageof 5